Drug application
TOBRAMYCIN AND DEXAMETHASONE (DEXAMETHASONE, TOBRAMYCIN)
Drugs@FDA ANDA 212715 · PADAGIS US
Key facts
| Drug name | TOBRAMYCIN AND DEXAMETHASONE |
|---|---|
| Active ingredients | DEXAMETHASONE, TOBRAMYCIN |
| Application type | ANDA |
| Application number | 212715 |
| Company | PADAGIS US |
| Dosage forms | SUSPENSION/DROPS, OPHTHALMIC |
| Strength | 0.1%;0.3% |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Feb 11, 2022 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.